BMAL1 and lung carcinoma: For example, knockout of Bmal1 in Kras- and p53-mutant lung cancer causes marked tumor progression in vivo [13], while MYC-induced repression of BMAL1 in human neuroblastoma drives decreased overall survival in a BMAL1-dependent manner [15].